Innate Pharma (France)

Innate Pharma (France)

Open Access statistics for Innate Pharma (France), France, covering academic research published from 2000 to 2023.

Open Access statistics for Innate Pharma (France), France, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

60%


Total
Publications

444


Total Open
Publications

267


Total
Citations

22K


Open Access
Percentage

60%


Total
Publications

444


Total Open
Publications

267


Total
Citations

22K

Website

download

Breakdown

19% 29% 12% 40%

Publisher Open

19%

Both

29%

Other Platform Open

12%

Closed

40%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

27%OA Journal

OA Journal 27%

59

Hybrid 30%

65

No Guarantees 43%

92

Other Platform Open

Domain 82%

148

Institution 43%

78

Other Internet 15%

28

Preprint 8%

14

Public 7%

12

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
145
Europe PMC
Domain
103
Le Centre pour la Communication Scientifique Directe - HAL - Aix-Marseille Université
Institution
32
Le Centre pour la Communication Scientifique Directe - HAL - Université de Nantes
Institution
26
Le Centre pour la Communication Scientifique Directe - HAL - memSIC
Other Internet
26
Le Centre pour la Communication Scientifique Directe - HAL - Inria
Institution
22
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
17
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
17
Le Centre pour la Communication Scientifique Directe - HAL - Inserm
Institution
10
Semantic Scholar
Public
7
1 / 7

Data updated 25 January 2024

Share

Share

Share